Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Altered chondrocyte differentiation, matrix mineralization and MEK-Erk1/2 signaling in an INPPL1 catalytic knock-out mouse model of opsismodysplasia.

Vande Catsyne CA, Sayyed SA, Molina-Ortiz P, Moes B, Communi D, Muller J, Heusschen R, Caers J, Azzi A, Erneux C, Schurmans S.

Adv Biol Regul. 2019 Sep 5:100651. doi: 10.1016/j.jbior.2019.100651. [Epub ahead of print]

2.

Multiple proteins arising from a single gene: The role of the Spa33 variants in Shigella T3SS regulation.

Kadari M, Lakhloufi D, Delforge V, Imbault V, Communi D, Smeesters P, Botteaux A.

Microbiologyopen. 2019 Sep 13:e932. doi: 10.1002/mbo3.932. [Epub ahead of print]

3.

GPRIN3 Controls Neuronal Excitability, Morphology, and Striatal-Dependent Behaviors in the Indirect Pathway of the Striatum.

Karadurmus D, Rial D, De Backer JF, Communi D, de Kerchove d'Exaerde A, Schiffmann SN.

J Neurosci. 2019 Sep 18;39(38):7513-7528. doi: 10.1523/JNEUROSCI.2454-18.2019. Epub 2019 Jul 30.

PMID:
31363062
4.

Mouse P2Y4 Nucleotide Receptor Is a Negative Regulator of Cardiac Adipose-Derived Stem Cell Differentiation and Cardiac Fat Formation.

Lemaire A, Vanorlé M, Horckmans M, di Pietrantonio L, Clouet S, Robaye B, Boeynaems JM, Communi D.

Stem Cells Dev. 2017 Mar 1;26(5):363-373. doi: 10.1089/scd.2016.0166. Epub 2016 Dec 23.

PMID:
27855539
5.

Loss of Mouse P2Y6 Nucleotide Receptor Is Associated with Physiological Macrocardia and Amplified Pathological Cardiac Hypertrophy.

Clouet S, Di Pietrantonio L, Daskalopoulos EP, Esfahani H, Horckmans M, Vanorlé M, Lemaire A, Balligand JL, Beauloye C, Boeynaems JM, Communi D.

J Biol Chem. 2016 Jul 22;291(30):15841-52. doi: 10.1074/jbc.M115.684118. Epub 2016 May 26.

6.

P2Y2R deficiency attenuates experimental autoimmune uveitis development.

Relvas LJ, Makhoul M, Dewispelaere R, Caspers L, Communi D, Boeynaems JM, Robaye B, Bruyns C, Willermain F.

PLoS One. 2015 Feb 18;10(2):e0116518. doi: 10.1371/journal.pone.0116518. eCollection 2015.

7.

Loss of mouse P2Y4 nucleotide receptor protects against myocardial infarction through endothelin-1 downregulation.

Horckmans M, Esfahani H, Beauloye C, Clouet S, di Pietrantonio L, Robaye B, Balligand JL, Boeynaems JM, Dessy C, Communi D.

J Immunol. 2015 Feb 15;194(4):1874-81. doi: 10.4049/jimmunol.1401364. Epub 2015 Jan 16.

8.

Connection between cardiac vascular permeability, myocardial edema, and inflammation during sepsis: role of the α1AMP-activated protein kinase isoform.

Castanares-Zapatero D, Bouleti C, Sommereyns C, Gerber B, Lecut C, Mathivet T, Horckmans M, Communi D, Foretz M, Vanoverschelde JL, Germain S, Bertrand L, Laterre PF, Oury C, Viollet B, Horman S, Beauloye C.

Crit Care Med. 2013 Dec;41(12):e411-22. doi: 10.1097/CCM.0b013e31829866dc.

PMID:
23963133
9.

Protective role of P2Y2 receptor against lung infection induced by pneumonia virus of mice.

Vanderstocken G, Van de Paar E, Robaye B, di Pietrantonio L, Bondue B, Boeynaems JM, Desmecht D, Communi D.

PLoS One. 2012;7(11):e50385. doi: 10.1371/journal.pone.0050385. Epub 2012 Nov 21.

10.

Gene deletion of P2Y4 receptor lowers exercise capacity and reduces myocardial hypertrophy with swimming exercise.

Horckmans M, Léon-Gómez E, Robaye B, Balligand JL, Boeynaems JM, Dessy C, Communi D.

Am J Physiol Heart Circ Physiol. 2012 Oct 1;303(7):H835-43. doi: 10.1152/ajpheart.00256.2012. Epub 2012 Aug 3.

11.

P2Y(4) nucleotide receptor: a novel actor in post-natal cardiac development.

Horckmans M, Robaye B, Léon-Gόmez E, Lantz N, Unger P, Dol-Gleizes F, Clouet S, Cammarata D, Schaeffer P, Savi P, Gachet C, Balligand JL, Dessy C, Boeynaems JM, Communi D.

Angiogenesis. 2012 Sep;15(3):349-60. doi: 10.1007/s10456-012-9265-1. Epub 2012 Mar 22.

PMID:
22437266
12.

ChemR23 dampens lung inflammation and enhances anti-viral immunity in a mouse model of acute viral pneumonia.

Bondue B, Vosters O, de Nadai P, Glineur S, De Henau O, Luangsay S, Van Gool F, Communi D, De Vuyst P, Desmecht D, Parmentier M.

PLoS Pathog. 2011 Nov;7(11):e1002358. doi: 10.1371/journal.ppat.1002358. Epub 2011 Nov 3.

13.

Processing of HEBP1 by cathepsin D gives rise to F2L, the agonist of formyl peptide receptor 3.

Devosse T, Dutoit R, Migeotte I, De Nadai P, Imbault V, Communi D, Salmon I, Parmentier M.

J Immunol. 2011 Aug 1;187(3):1475-85. doi: 10.4049/jimmunol.1003545. Epub 2011 Jun 27.

14.

P2Y2 receptor regulates VCAM-1 membrane and soluble forms and eosinophil accumulation during lung inflammation.

Vanderstocken G, Bondue B, Horckmans M, Di Pietrantonio L, Robaye B, Boeynaems JM, Communi D.

J Immunol. 2010 Sep 15;185(6):3702-7. doi: 10.4049/jimmunol.0903908. Epub 2010 Aug 18.

15.

ATP confers tumorigenic properties to dendritic cells by inducing amphiregulin secretion.

Bles N, Di Pietrantonio L, Boeynaems JM, Communi D.

Blood. 2010 Oct 28;116(17):3219-26. doi: 10.1182/blood-2010-01-265611. Epub 2010 Jul 22.

PMID:
20651071
16.

Angiotensin II inhibits insulin-stimulated GLUT4 translocation and Akt activation through tyrosine nitration-dependent mechanisms.

Csibi A, Communi D, Müller N, Bottari SP.

PLoS One. 2010 Apr 7;5(4):e10070. doi: 10.1371/journal.pone.0010070.

17.

SHIP2 (SH2 domain-containing inositol phosphatase 2) SH2 domain negatively controls SHIP2 monoubiquitination in response to epidermal growth factor.

De Schutter J, Guillabert A, Imbault V, Degraef C, Erneux C, Communi D, Pirson I.

J Biol Chem. 2009 Dec 25;284(52):36062-76. doi: 10.1074/jbc.M109.064923. Epub 2009 Oct 30.

18.

NF546 [4,4'-(carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)-carbonylimino))-bis(1,3-xylene-alpha,alpha'-diphosphonic acid) tetrasodium salt] is a non-nucleotide P2Y11 agonist and stimulates release of interleukin-8 from human monocyte-derived dendritic cells.

Meis S, Hamacher A, Hongwiset D, Marzian C, Wiese M, Eckstein N, Royer HD, Communi D, Boeynaems JM, Hausmann R, Schmalzing G, Kassack MU.

J Pharmacol Exp Ther. 2010 Jan;332(1):238-47. doi: 10.1124/jpet.109.157750. Epub 2009 Oct 8.

PMID:
19815812
19.

Activation of dual oxidases Duox1 and Duox2: differential regulation mediated by camp-dependent protein kinase and protein kinase C-dependent phosphorylation.

Rigutto S, Hoste C, Grasberger H, Milenkovic M, Communi D, Dumont JE, Corvilain B, Miot F, De Deken X.

J Biol Chem. 2009 Mar 13;284(11):6725-34. doi: 10.1074/jbc.M806893200. Epub 2009 Jan 14.

20.

Extracellular nucleotides and interleukin-8 production by ARPE cells: potential role of danger signals in blood-retinal barrier activation.

Relvas LJ, Bouffioux C, Marcet B, Communi D, Makhoul M, Horckmans M, Blero D, Bruyns C, Caspers L, Boeynaems JM, Willermain F.

Invest Ophthalmol Vis Sci. 2009 Mar;50(3):1241-6. doi: 10.1167/iovs.08-1902. Epub 2008 Nov 21.

PMID:
19029040
21.

Role of neutrophil proteinase 3 and mast cell chymase in chemerin proteolytic regulation.

Guillabert A, Wittamer V, Bondue B, Godot V, Imbault V, Parmentier M, Communi D.

J Leukoc Biol. 2008 Dec;84(6):1530-8. doi: 10.1189/jlb.0508322. Epub 2008 Aug 27.

PMID:
18753310
22.

HDGF is dephosphorylated during the early steps of endothelial cell apoptosis in a caspase-dependent way.

Clermont F, Gonzalez NS, Communi D, Franken S, Dumont JE, Robaye B.

J Cell Biochem. 2008 Jul 1;104(4):1161-71. doi: 10.1002/jcb.21788.

PMID:
18465786
23.

Modulation of murine dendritic cell function by adenine nucleotides and adenosine: involvement of the A(2B) receptor.

Ben Addi A, Lefort A, Hua X, Libert F, Communi D, Ledent C, Macours P, Tilley SL, Boeynaems JM, Robaye B.

Eur J Immunol. 2008 Jun;38(6):1610-20. doi: 10.1002/eji.200737781.

24.

Molecular mechanisms of extracellular adenine nucleotides-mediated inhibition of human Cd4(+) T lymphocytes activation.

Duhant X, Suarez Gonzalez N, Schandené L, Goldman M, Communi D, Boeynaems JM.

Purinergic Signal. 2005 Dec;1(4):377-81. doi: 10.1007/s11302-005-8077-9. Epub 2005 Dec 3.

25.

The fate of P2Y-related orphan receptors: GPR80/99 and GPR91 are receptors of dicarboxylic acids.

Gonzalez NS, Communi D, Hannedouche S, Boeynaems JM.

Purinergic Signal. 2004 Dec;1(1):17-20. doi: 10.1007/s11302-004-5071-6.

26.

Gene expression profiling defines ATP as a key regulator of human dendritic cell functions.

Bles N, Horckmans M, Lefort A, Libert F, Macours P, El Housni H, Marteau F, Boeynaems JM, Communi D.

J Immunol. 2007 Sep 15;179(6):3550-8.

27.

Extracellular nucleotides induce COX-2 up-regulation and prostaglandin E2 production in human A549 alveolar type II epithelial cells.

Marcet B, Libert F, Boeynaems JM, Communi D.

Eur J Pharmacol. 2007 Jul 2;566(1-3):167-71. Epub 2007 Apr 14.

PMID:
17481603
28.

Extracellular nucleotides regulate CCL20 release from human primary airway epithelial cells, monocytes and monocyte-derived dendritic cells.

Marcet B, Horckmans M, Libert F, Hassid S, Boeynaems JM, Communi D.

J Cell Physiol. 2007 Jun;211(3):716-27.

PMID:
17295217
29.

Peptidoglycan recognition proteins with amidase activity in early deuterostomes (Echinodermata).

Coteur G, Mellroth P, De Lefortery C, Gillan D, Dubois P, Communi D, Steiner H.

Dev Comp Immunol. 2007;31(8):790-804. Epub 2006 Dec 14.

PMID:
17240448
30.

F2L, a peptide derived from heme-binding protein, chemoattracts mouse neutrophils by specifically activating Fpr2, the low-affinity N-formylpeptide receptor.

Gao JL, Guillabert A, Hu J, Le Y, Urizar E, Seligman E, Fang KJ, Yuan X, Imbault V, Communi D, Wang JM, Parmentier M, Murphy PM, Migeotte I.

J Immunol. 2007 Feb 1;178(3):1450-6.

31.

The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues.

Parolini S, Santoro A, Marcenaro E, Luini W, Massardi L, Facchetti F, Communi D, Parmentier M, Majorana A, Sironi M, Tabellini G, Moretta A, Sozzani S.

Blood. 2007 May 1;109(9):3625-32. Epub 2007 Jan 3.

PMID:
17202316
32.

Lack of minocycline efficiency in genetic models of Huntington's disease.

Mievis S, Levivier M, Communi D, Vassart G, Brotchi J, Ledent C, Blum D.

Neuromolecular Med. 2007;9(1):47-54.

PMID:
17114824
33.

Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses.

Migeotte I, Communi D, Parmentier M.

Cytokine Growth Factor Rev. 2006 Dec;17(6):501-19. Epub 2006 Nov 2. Review.

PMID:
17084101
34.
35.

Modulation of inflammation by extracellular nucleotides.

Boeynaems JM, Communi D.

J Invest Dermatol. 2006 May;126(5):943-4.

36.

Extracellular adenine nucleotides inhibit the release of major monocyte recruiters by human monocyte-derived dendritic cells.

Horckmans M, Marcet B, Marteau F, Bulté F, Maho A, Parmentier M, Boeynaems JM, Communi D.

FEBS Lett. 2006 Feb 6;580(3):747-54. Epub 2006 Jan 9.

37.

Synthesis and structure-activity relationships of suramin-derived P2Y11 receptor antagonists with nanomolar potency.

Ullmann H, Meis S, Hongwiset D, Marzian C, Wiese M, Nickel P, Communi D, Boeynaems JM, Wolf C, Hausmann R, Schmalzing G, Kassack MU.

J Med Chem. 2005 Nov 3;48(22):7040-8.

PMID:
16250663
38.

Thrombospondin-1 and indoleamine 2,3-dioxygenase are major targets of extracellular ATP in human dendritic cells.

Marteau F, Gonzalez NS, Communi D, Goldman M, Boeynaems JM, Communi D.

Blood. 2005 Dec 1;106(12):3860-6. Epub 2005 Aug 23.

PMID:
16118322
39.

Neutrophil-mediated maturation of chemerin: a link between innate and adaptive immunity.

Wittamer V, Bondue B, Guillabert A, Vassart G, Parmentier M, Communi D.

J Immunol. 2005 Jul 1;175(1):487-93.

40.

Overview of the P2 receptors.

Boeynaems JM, Communi D, Gonzalez NS, Robaye B.

Semin Thromb Hemost. 2005 Apr;31(2):139-49. Review.

PMID:
15852217
41.

Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin.

Vermi W, Riboldi E, Wittamer V, Gentili F, Luini W, Marrelli S, Vecchi A, Franssen JD, Communi D, Massardi L, Sironi M, Mantovani A, Parmentier M, Facchetti F, Sozzani S.

J Exp Med. 2005 Feb 21;201(4):509-15.

42.

Revascularization of ischemic tissues by PDGF-CC via effects on endothelial cells and their progenitors.

Li X, Tjwa M, Moons L, Fons P, Noel A, Ny A, Zhou JM, Lennartsson J, Li H, Luttun A, Pontén A, Devy L, Bouché A, Oh H, Manderveld A, Blacher S, Communi D, Savi P, Bono F, Dewerchin M, Foidart JM, Autiero M, Herbert JM, Collen D, Heldin CH, Eriksson U, Carmeliet P.

J Clin Invest. 2005 Jan;115(1):118-27.

43.

Identification and characterization of an endogenous chemotactic ligand specific for FPRL2.

Migeotte I, Riboldi E, Franssen JD, Grégoire F, Loison C, Wittamer V, Detheux M, Robberecht P, Costagliola S, Vassart G, Sozzani S, Parmentier M, Communi D.

J Exp Med. 2005 Jan 3;201(1):83-93. Epub 2004 Dec 28.

44.

Involvement of multiple P2Y receptors and signaling pathways in the action of adenine nucleotides diphosphates on human monocyte-derived dendritic cells.

Marteau F, Communi D, Boeynaems JM, Suarez Gonzalez N.

J Leukoc Biol. 2004 Oct;76(4):796-803. Epub 2004 Jul 7.

PMID:
15240747
45.

Identification of fructosamine residues deglycated by fructosamine-3-kinase in human hemoglobin.

Delpierrre G, Vertommen D, Communi D, Rider MH, Van Schaftingen E.

J Biol Chem. 2004 Jun 25;279(26):27613-20. Epub 2004 Apr 21.

46.

The C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency.

Wittamer V, Grégoire F, Robberecht P, Vassart G, Communi D, Parmentier M.

J Biol Chem. 2004 Mar 12;279(11):9956-62. Epub 2003 Dec 29.

47.

Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids.

Wittamer V, Franssen JD, Vulcano M, Mirjolet JF, Le Poul E, Migeotte I, Brézillon S, Tyldesley R, Blanpain C, Detheux M, Mantovani A, Sozzani S, Vassart G, Parmentier M, Communi D.

J Exp Med. 2003 Oct 6;198(7):977-85.

48.

Pharmacological characterization of the human P2Y13 receptor.

Marteau F, Le Poul E, Communi D, Communi D, Labouret C, Savi P, Boeynaems JM, Gonzalez NS.

Mol Pharmacol. 2003 Jul;64(1):104-12.

PMID:
12815166
49.

Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1.

Autiero M, Waltenberger J, Communi D, Kranz A, Moons L, Lambrechts D, Kroll J, Plaisance S, De Mol M, Bono F, Kliche S, Fellbrich G, Ballmer-Hofer K, Maglione D, Mayr-Beyrle U, Dewerchin M, Dombrowski S, Stanimirovic D, Van Hummelen P, Dehio C, Hicklin DJ, Persico G, Herbert JM, Communi D, Shibuya M, Collen D, Conway EM, Carmeliet P.

Nat Med. 2003 Jul;9(7):936-43.

PMID:
12796773
50.

Extracellular adenine nucleotides inhibit the activation of human CD4+ T lymphocytes.

Duhant X, Schandené L, Bruyns C, Gonzalez NS, Goldman M, Boeynaems JM, Communi D.

J Immunol. 2002 Jul 1;169(1):15-21.

Supplemental Content

Loading ...
Support Center